Clorox Positioned for Future Growth
In a recent analysis, Jefferies analyst Kaumil Gajrawala has upgraded the Clorox Company (NYSE: CLX) from Hold to Buy, significantly raising the price target from $174 to $187. This upgrade marks a turning point as the company looks to recover its previously strong market position.
Anticipated Economic Profit Growth
According to Gajrawala, Clorox is on the verge of regaining its status as a leader in economic profit growth and capital returns. Historically, this performance has enabled the company to secure a valuation premium of 30% over its competitors.
Signs of Improvement
Recent indicators suggest that Clorox is set for a considerable uptick in topline growth. The company is starting to gain momentum as operating leverage becomes increasingly attainable. This shift indicates a positive trajectory for Clorox, especially after facing numerous challenges in recent years.
Challenges Faced
From 2020 to 2024, Clorox faced significant hurdles including the impacts of COVID-19, supply chain disruptions, rising inflation, and concerns regarding cybersecurity. These factors contributed to a lag in growth reinvestments compared to industry peers.
Strategic Changes and Expectations
Despite these challenges, Gajrawala points out that Clorox is beginning to adapt. With upcoming ERP deployments expected to be expensed and a U.S. rollout anticipated by the fiscal fourth quarter, the company aims to streamline its innovation efforts. Enhancing revenue growth management (RGM) capabilities and improving SG&A leverage are key strategies for driving future earnings.
Long-term Growth Projections
The analyst projects that Clorox will experience a robust three-year organic sales compound annual growth rate (CAGR) of +3.6% through fiscal 2028. This outlook aligns with the company's goal to achieve organic sales growth of +3-5%. Expected feedback from U.S. operations is positive, with anticipated growth of approximately +3% domestically and +5.5% internationally. Notably, U.S. sales are projected to rebound to fiscal 2023 levels by fiscal 2025.
Positive Indicators
Early signs of improvement are already apparent. Increased trade spend has shown promising results, giving further credence to the analyst's optimistic forecasts.
Current Market Performance
As of the latest market check, shares of Clorox (CLX) have risen by 0.96%, trading at $164.47. The market’s response to the analyst's report underscores growing investor confidence in the company's recovery and future growth potential.
Frequently Asked Questions
What recent changes have analysts observed in Clorox Company?
Analysts have noted improved topline growth and operating leverage, facilitating a potential earnings rebound.
What is the new price target for Clorox stock?
The new price target for Clorox stock has been raised to $187 from a previous target of $174.
How is Clorox addressing its past challenges?
Clorox is implementing ERP deployments, enhancing innovation capabilities, and focusing on revenue growth management to overcome past challenges.
What long-term growth rate is projected for Clorox?
Analysts project a three-year organic sales CAGR of +3.6%, with sales expected to rebound in the coming fiscal years.
How did the market react to the analyst's upgrade of Clorox?
The market reacted positively, with CLX shares trading up 0.96% to $164.47 following the upgrade news.
